CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease

EMBO Journal

Volumn 15, Issue 19, 1996, Pages 5167-5176

  Smith, Kenneth G C ^a   Strasser, Andreas ^a   Vaux, David L ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Apoptosis; CD95 (Fas APO 1); crmA; Interleukin 1 converting enzyme

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CONTROLLED STUDY; COWPOX VIRUS; ENZYME ACTIVITY; GAMMA RADIATION; HYPERPLASIA; LYMPHADENOPATHY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALIA; COWPOX VIRUS; MAMMALIA; MUS MUSCULUS;

EID: 0029834497     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00901.x     Document Type: Article

References (67)

1. Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N. and Nagata, S. (1996) Enhanced and accelerated lymphoproliferation in fas-null mice. Proc. Natl Acad. Sci. USA, 93, 2131-2136.
2. Alderson, M.R., Armitage, R.J., Maraskovsky, E., Tough, T.W., Roux, E., Schooley, K., Ramsdell, F. and Lynch, D.H. (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med., 178, 2231-2235.
3. Alderson, M.R., Tough, T.W., Braddy, S., Davis, S.T., Roux, E., Schooley, K., Miller, R.E. and Lynch, D.H. (1994) Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol., 6, 1799-1806.
4. Alderson, M.R. et al. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77.
5. Boldin, M.P., Varfolomeev, E.E., Pancer Z., Mett, I.L., Camonis, J.H. and Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain. J. Biol. Chem., 270, 7795-7798.
6. Brunner, T. et al. (1995) Cell-autonomous Fas (CD95) Fas-ligand interaction mediates activation induced apoptosis in T-cell hybridomas. Nature, 373, 441-444.
7. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. and Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512.
8. L function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem., 271, 4573-4576.
9. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
10. Cohen, P.L. and Eisenberg, R.A. (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269.
11. Dhein, J., Walczak, H., Baumler, C., Debatin, K.M. and Krammer, P.H. (1995) Autocrine T-cell suicide mediated by APO-1(Fas/CD95). Nature, 373, 438-41.
12. Eisenberg, R.A., Sobel, E.S., Reap, E.A., Halpern, M.D. and Cohen, P.L. (1994) The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice. Semin. Immunol., 6, 49-54.
13. Enari, M., Hug, H. and Nagata, S. (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature, 375, 78-81.
14. Fernandes-Alnemri, T., Litwack, G. and Alnemri, E.S. (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 β-converting enzyme. J. Biol. Chem., 269, 30761-30764.
15. Fernandes-Alnemri, T., Litwack, G. and Alnemri, E.S. (1995) Mch2, a new member of the apoptotic Ced-3/ICE cysteine protease gene family. Cancer Res., 55, 2737-2742.
16. Gagliardini, V., Fernandez, P.A., Lee, R.K.K., Drexler, H.C.A., Rotello, R.J., Fishman, M.C. and Yuan, J. (1994) Prevention of vertebrate neuronal death by the crmA gene. Science, 263, 826-828.
17. Itoh, N., Tsujimoto, Y. and Nagata, S. (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol., 151, 621-627.
18. Jaattela, M., Benedict, M., Tewari, M., Shayman, J.A. and Dixit, V.M. (1995) Bcl-x and bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A(2) in breast carcinoma cells. Oncogene, 10, 2297-2305.
19. Ju, S.T., Panka, D.J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D.H., Stanger, B.Z. and Marshak, R.A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature, 373, 444-448.
20. Kagi, D., Seiler, P., Pavlovic J., Ledermann, B., Burki, K., Zinkernagel, R.M. and Hengartner, H. (1995) The roles of perform- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol., 25, 3256-3262.
21. Kuida, K., Lippke, J.A., Ku, G., Harding, M.W., Livingston, D.J., Su M.S. and Flavell, R.A. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1 β converting enzyme. Science, 267, 2000-2003.
22. Kumar, S. (1995) ICE-like proteases in apoptosis. Trends Biochem. Sci., 20, 198-202.
23. Kumar, S., Kinoshita, M., Noda, M., Copeland, N.G. and Jenkins, N.A. (1994) Induction of apoptosis by the mouse nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene Ced 3 and the mammalian IL-1 β converting enzyme. Genes Dev., 8, 1613-1626.
24. Lacronique, V. et al. (1996) Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nature Medicine, 2, 80-86.
25. Lang, G., Mamalaki, C., Greenberg, D., Yannoutsos, N. and Kioussis, D. (1991) Deletion analysis of the human CD2 gene locus control region in transgenic mice. Nucleic Acids Res., 19, 5851-5856.
26. Li, P. et al. (1995) Mice deficient in IL-1β converting enzyme are defective in production of mature IL-1-β and resistant to endotoxic shock. Cell, 80, 401-411.
27. Los, M. et al. (1995) Requirement of an ICE/Ced-3 protease for Fas/APO-1-mediated apoptosis. Nature, 375, 81-83.
28. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature, 370, 650-652
29. Lowin, B., Peitsch, M.C. and Tschopp, J. (1995) Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol., 198, 1-24.
30. MacDonald, H.R., Schneider, R., Lees, R.K., Howe, R.C. Acha, O.H., Festenstein, H., Zinkernagel, R.M. and Hengartner, H. (1988) T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature, 332, 40-45.
31. Mariani, S.M., Matiba, B., Armandola, E.A. and Krammer, P.H. (1994) The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol., 24, 3119-3123.
32. McDonnell, T.J. and Korsmeyer, S.J. (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature, 349, 254-256.
33. Memon, S.A., Moreno, M.B., Petrak, D. and Zacharchuk, C.M. (1995) Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol., 155, 4644-4652.
34. Miura, M., Zhu, H., Rotello, R., Hartweig, E.A. and Yuan, J.Y. (1993) Induction of apoptosis in fibroblasts by IL-1-β converting enzyme, a mammalian homolog of the C.elegans cell death gene Ced-3. Cell, 75, 653-660.
35. Miura, M., Friedlander, R.M. and Yuan, J.Y. (1995) Tumor necrosis factor-induced apoptosis is mediated by a crmA-sensitive cell death pathway. Proc. Natl Acad. Sci. USA, 92, 8318-8322.
36. Munday, N.A., Vaillancourt, J.P., Ali, A., Casano, F.J., Miller D.K., Molineaux, S.M., Yamin, T.T, Yu, V.L. and Nicholson, D.W. (1995) Molecular cloning and pro-apoptotic activity of ICE(rel)ii and ICE(rel)iii, members of the ICE/Ced-3 family of cysteine proteases. J. Biol. Chem., 270, 15870-15876.
37. Nagata, S. and Golstein, P. (1995) The Fas death factor. Science, 267, 1449-1456.
38. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F. and Riccardi, C. (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139, 271-279.
39. Nicholson, D.W. et al. (1995) Identification and inhibition of the ICE/Ced-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
40. Pickup, D.J., Ink, B.S., Hu, W., Ray, C.A. and Joklik, W.K. (1986) Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc. Natl Acad. Sci. USA, 83, 7698-7702.
41. Pullen, A.M. Marrack, P. and Kappler, J.W. (1988) The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature, 335, 796-801.
42. Quan, L.T., Caputo, A., Bleackley, R.C., Pickup, D.J. and Salvesen, G.S. (1995) Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J. Biol. Chem., 270, 10377-10379.
43. Ray, C.A., Black, R.A., Kronheim, S.R., Greenstreet T.A., Sleath, P.R., Salvesen, G.S. and Pickup, D.J. (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell, 69, 597-604.
44. Reap, E.A., Leslie, D., Abrahams, M., Eisenberg, R.A. and Cohen, P.L. (1995) Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol., 154, 936-943
45. Robb, L., Rasko, J.E., Bath, M.L., Strasser, A. and Begley, C.G. (1995) scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene, 10, 205-209.
46. Rodriguez, I., Matsuura, K., Khatib, K., Reed, J.C., Nagata, S. and Vassalli, P. (1996) A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med., 183, 1031-1036.
47. Rouvier, E., Luciani, M.F. and Golstein, P. (1993) Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med., 177, 195-200.
48. Russell, J.H., Rush, B., Weaver, C. and Wang, R. (1993) Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl Acad. Sci. USA, 90, 4409-4413.
49. Russell, J.H., Rush, B.J., Abrams, S.I. and Wang, R. (1992) Sensitivity of T cells to anti-CD3-stimulated suicide is independent of functional phenotype. Eur. J. Immunol., 22, 1655-1658.
50. Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O. and Korsmeyer, S.J. (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888.
51. Singer, G.G., Carrera, A.C., Marshak-Rothstein, A., Martineza, C. and Abbas, A.K. (1994) Apoptosis, Fas and systemic autoimmunity - the MRL-lpr/lpr model. Curr. Op. Immunol., 6, 913-920.
52. Smith, K.G.C., Nossal, G.J.V. and Tarlinton, D.M. (1995) Fas is highly expressed in the germinal center, but is not required for regulation of the B cell response to antigen. Proc. Natl Acad. Sci. USA, 92, 11628-11632.
53. Strasser, A., Harris, A.W. and Cory, S. (1991) Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67, 889-899.
54. Strasser, A., Harris, A.W., Huang D., Krammer, P.H. and Cory, S. (1995) Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J., 14, 6136-6147.
55. Strasser, A., Harris, A.W., Vaux, D.L., Webb, E., Bath, M.L., Adams, J.M. and Cory, S. (1990) Abnormalities of the immune system induced by dysregulaled bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol., 166, 175-181.
56. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T. and Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76, 969-976.
57. Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M. and Arai, N. (1988) SR α promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol., 8, 466-472.
58. Tewari, M. and Dixit, V.M. (1995) Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270, 3255-3260.
59. Tewari, M., Quan, L.T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D.R., Poirier, G.G., Salvesen, G.S. and Dixit, V.M. (1995a) Yama/CPP32-β, a mammalian homolog of Ced-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801-809.
60. Tewari, M., Telford, W.G., Miller, R.A. and Dixit, V.M. (1995b) CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem., 270, 22705-22708.
61. Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Moller, P., Falk, W., Debatin, K.M. and Krammer, P.H. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305.
62. Vaux, D.L., Cory, S. and Adams, J.M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
63. Vaux, D.L., Haecker, G. and Strasser, A. (1994) An evolutionary perspective on apoptosis. Cell, 76, 777-779.
64. Vaux, D.L., Weissman, I.L., and Kim, S.K. (1992) Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science, 258, 1955-1957.
65. Wu, J., Zhou, T., Zhang, J., He, J., Gause, W.C. and Mountz, J.D. (1994) Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl Acad. Sci. USA, 91, 2344-2348.
66. Yonehara, S., Ishii, A. and Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med., 169, 1747-1756.
67. Yuan, J.Y., Shaham, S., Ledoux, S., Ellis, H.M. and Horvitz, H.R. (1993) The C.elegans cell death gene ced 3 encodes a protein similar to mammalian interleukin-1β converting enzyme. Cell, 75, 641-652.